Clinical Trial Update: Study to Compare Delafloxacin to Moxifloxacin for the Treatment of Adults With Community-acquired Bacterial Pneumonia [Phase 3]

View source ↗

Summary

Phase 3 trial comparing delafloxacin to moxifloxacin for adults with community-acquired bacterial pneumonia has completed and results were posted in 2020.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Community-acquired Bacterial Pneumonia

Drugs mentioned

• Delafloxacin (delafloxacin)
• Moxifloxacin (moxifloxacin)

Snippet

Sponsor: Melinta Therapeutics, Inc. | Conditions: Community Acquired Bacterial Pneumonia | Phase 3 | Status: COMPLETED | Results posted: 2020-02-27